Classically, p70S6K has been characterized as a versatile kinase for the regulation of mRNA translation through S6 phosphorylation, and pharmacological targeting of p70S6K has been found to result in effective inhibition of cancer progression. This evidence concerns the gene RPS6KB1 and cancer.